跳至主要内容
临床试验/NCT01891578
NCT01891578Unknown不适用

Evaluation of Immunological Reconstitution After Haploidentical Bone Marrow Transplantation Using a Nonmyeloablative Preparative Regimen and Post-transplant Cyclophosphamide, in Patients With Poor Prognosis Lymphomas

Armando Santoro, MD1 个研究点 分布在 1 个国家目标入组 23 人开始时间: 2011年1月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
23
试验地点
1
主要终点
Evaluation of T lymphocytes and NK cells absolute number

研究概览

简要总结

Evaluation of immunological reconstitution after haploidentical BMT using a nonmyeloablative preparative regimen and post-transplant cyclophosphamide in patients with poor prognosis lymphoma

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with lymphoma (any histology) relapsed after high dose chemotherapy and in partial remission, complete remission or stable disease after the last CT line that
  • Signed informed consent to perform an haploidentical allo-BMT using a nonmyeloablative preparative regimen and post-transplant cyclophosphamide

排除标准

  • 未提供

结局指标

主要结局

Evaluation of T lymphocytes and NK cells absolute number

时间窗: 1 year

次要结局

  • Evaluation of discrete T-cells populations(1 year)
  • Evaluation of antigen-specific T cell populations(1 year)
  • Evaluation of antigen-specific T lymphocyte's functionality(1 year)
  • Evaluation of cytokines production by IL-2 and anti-CD16 activated NK cells(1 year)

研究者

发起方
Armando Santoro, MD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Armando Santoro, MD

MD

Istituto Clinico Humanitas

研究点 (1)

Loading locations...

相似试验